Suchen
NeuroOne Medical Technologies Corp
NMTCZur Watchlist hinzufügen
1.360USD
0.0000.00%
Trading geöffnet 09/18, 14:02（ET）
11.84MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über NeuroOne Medical Technologies Corp Unternehmen
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
NeuroOne Medical Technologies Corp Profil
BörsenkürzelNMTC
Name des UnternehmensNeuroOne Medical Technologies Corp
IPO-datumNov 09, 2012
CEORosa (David A)
Anzahl der mitarbeiter17
WertpapierartOrdinary Share
GeschäftsjahresendeNov 09
Addresse7599 Anagram Dr
StadtEDEN PRAIRIE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55344-7399
Telefon19524261383
Websitehttps://nmtc1.com/
BörsenkürzelNMTC
IPO-datumNov 09, 2012
CEORosa (David A)
Führungskräfte von NeuroOne Medical Technologies Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
23.11K
-43.27%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von NeuroOne Medical Technologies Corp?
Die fünf größten Anteilseigner von NeuroOne Medical Technologies Corp sind: Mr. David A. (Dave) Rosa
Wie viele Institutionen halten Anteile an NeuroOne Medical Technologies Corp (NMTC)?
Mit Stand vom 2026Q1 halten 58 Institutionen Anteile an NeuroOne Medical Technologies Corp, mit einem Gesamtmarktwert von etwa 2.36M, was 28.07% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -230396.00 gestiegen.